Skip to content
Magazine
Sunday, August 3, 2025
SUBSCRIBE
  • About Us
  • Belgium News
    • Belgium Police News
    • Brussels News
  • EU Institutions News
    • European Commission News
    • European Parliament News
    • European Council News
  • Europe News
  • World News
  • Belgium Business News
  • Culture and Society News
  • In Depth
    • Ambassador’s Corner
    • The American Angle
    • Sustainable Perspective
    • Europe With Transparency
    • Place de la Bourse
    • The Macro-Economist
    • Southeast Europe
  • About Us
  • Belgium News
    • Belgium Police News
    • Brussels News
  • EU Institutions News
    • European Commission News
    • European Parliament News
    • European Council News
  • Europe News
  • World News
  • Belgium Business News
  • Culture and Society News
  • In Depth
    • Ambassador’s Corner
    • The American Angle
    • Sustainable Perspective
    • Europe With Transparency
    • Place de la Bourse
    • The Macro-Economist
    • Southeast Europe
SUBSCRIBE

EU Special COVID-19: EU-wide corona testing and vaccine supply on the EC agenda

Marta Pacheco by Marta Pacheco
21 September 2020
in European Commission News, Features

Vaccines: Commission secures second deal

As the race for a vaccine mounts, the European Commission announced an official agreement with a second manufacturer, Sanofi-GSK, last Friday. Earlier, on 9 September, the EU executive had concluded talks with BioNTech-Pfizer. By securing the second contract, the EC will enable EU member states to purchase up to 300 million doses of the Sanofi-GSK vaccine. At a global level, Sanofi and GSK will also attempt to provide a significant portion of their vaccine supply in a timely manner through an alliance with the COVID-19 Vaccines Global Access (COVAX) facility, the vaccine pillar of the Access to COVID-19 Tools Accelerator for lower and middle-income countries. 

Commission’s recommendations for testing

The Commission has published recommendations for a common EU-testing approach which set out concrete steps to support countries in the planning and organisation of their testing efforts during the different stages of the pandemic. The Health Security Committee, an advisory group within DG SANTE, has endorsed the recommendations with a view to streamlining national approaches and ensuring more coherent COVID-19 testing across the EU.

The European Centre for Disease Prevention and Control (ECDC) has also published a report on COVID-19 testing strategies and objectives.

Funds for the transport of medical items

The EU is providing financial support through the Emergency Support Instrument (ESI) to 18 EU countries and to the UK to transport essential medical items to Europe with funding totalling €150 million. ESI has enabled the EU to finance cargo shipments between April and September this year, including life-saving personal protective equipment (PPE), medicines and medical equipment. For instance, it supported the transport of a shared shipment of more than 1,000 tonnes of essential PPE to the Czech Republic and Slovakia. Thanks to this instrument, the EU also financed the transport of more than 1,000 tonnes of PPE bought by the Italian Extraordinary Commissioner for the coronavirus emergency, and more than 400 tonnes of goggles, disposable gowns, masks and protective clothing to Lithuania by plane and train. 

Commission’s contribution to COVAX

The Commission confirmed its participation in the COVAX Facility for equitable access to affordable COVID-19 vaccines, following its expression of interest on 31 August and its announcement of a contribution of 400 million euros. In a joint effort between the Commission and the 27 EU countries, Team Europe will contribute an initial €230 million in cash through a loan from the European Investment Bank, backed by the same amount in guarantees from the EU budget. A contribution of €230 million is equivalent to reserves or options to buy 88 million doses, which the EU would transfer to eligible Advanced Market Commitment (AMC) countries. This contribution is complemented with €170 million in financial guarantees from the EU budget.

EU-RESPONSE: Commission supports global clinical research

The Commission announced that it will support international clinical research networks with €15.7 million. This ambitious new research initiative — EU-RESPONSE —will establish a clinical research network to treat COVID-19 and other emerging infectious diseases. The funding is part of the Commission’s 1.4 billion euros pledge, one billion euros of which comes from Horizon 2020, for coronavirus research and innovation intended for the development of vaccines, new treatments and diagnostic tools to prevent the spread of the virus.

@EU_Commission

@EU_Health

@ECDC_EU

Related News:

  • UK COVID-19 testing hits supply snag
  • Italian firm ReiThera in early talks to supply corona vaccine to EU
  • France will not join EU-wide corona tracing network
  • Commission reaches deal with Novanax for COVID-19 vaccine supply
Tags: Covid-19European Commission
Next Post

Belarus opposition leader asks European Union for further support

Latest post

EU-elections-UK

EU elections: UK looks on from the “outside”

1 year ago
Galeries-Royales-Saint-Hubert

What Makes Galeries Royales Saint-Hubert an “Institution”?

1 year ago

Most Read

    Follow Brussels Morning
    Facebook Twitter Youtube Linkedin

    Browse Important News

    Belgium News
    Brussels News
    Culture and Society News
    Economy News
    EU Institutions News
    European Commission News
    European Council News
    European Parliament News
    Europe News
    Health And Fitness News
    Southeast Europe News
    Sustainable Perspective
    World News
    Diplomacy News
    US Elections News

    About Us

    Brussels Morning is a daily online newspaper based in Belgium. BM publishes unique and independent coverage on international and European affairs. With a Europe-wide perspective, BM covers policies and politics of the EU, significant Member State developments, and looks at the international agenda with a European perspective.

    More Info

    • About Us
    • Advertise With Us
    • Contact Us
    • Cookies Policy

    Join Our Newsletter

    Brussels Morning Newspaper – All Rights Reserved © 2024

    No Result
    View All Result
    • Home
    • About Us
    • Belgium News
      • Belgium Police News
      • Brussels News
    • Brussels Bubble
      • European Parliament News
      • European Commission News
      • European Council News
    • Wider Europe
      • Member States
    • World News
    • Business & Society
    • Europe With Transparency
    • Culture & Society
    • Policy Talks
      • Place de la Bourse
      • The Macro-Economist
      • Sustainable Perspective
      • Ambassador’s Corner
      • The American Angle
      • Southeast Europe
    • Print Magazine

    Brussels Morning Newspaper - All Rights Reserved © 2020

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
    Cookie settingsACCEPT
    Privacy & Cookies Policy

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
    Non-necessary
    Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
    SAVE & ACCEPT